Behçet's syndrome: response to infliximab after failure of etanercept
Open Access
- 1 October 2002
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 41 (10) , 1213-1214
- https://doi.org/10.1093/rheumatology/41.10.1213-c
Abstract
Sir, Anti‐tumour necrosis factor α (TNF‐α) therapy is being used with considerable success to suppress disease activity in patients with Behçet's syndrome (BS) [1–3]. We report a patient with refractory BS who failed to respond to etanercept but who responded dramatically to infliximab.Keywords
This publication has 3 references indexed in Scilit:
- Remission of Behçet's syndrome with TNFα blocking treatmentAnnals of the Rheumatic Diseases, 2002
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximabRheumatology, 2001